Phibro Animal Health Corporation (PAHC)
NASDAQ: PAHC · Real-Time Price · USD
32.43
-0.61 (-1.85%)
At close: Jun 5, 2026, 4:00 PM EDT
32.84
+0.41 (1.26%)
After-hours: Jun 5, 2026, 7:36 PM EDT
Phibro Animal Health Revenue
Phibro Animal Health had revenue of $383.54M in the quarter ending March 31, 2026, with 10.27% growth. This brings the company's revenue in the last twelve months to $1.50B, up 25.98% year-over-year. In the fiscal year ending June 30, 2025, Phibro Animal Health had annual revenue of $1.30B with 27.37% growth.
Revenue (ttm)
$1.50B
Revenue Growth
+25.98%
P/S Ratio
0.88
Revenue / Employee
$606,078
Employees
2,475
Market Cap
1.32B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 1.30B | 278.54M | 27.37% |
| Jun 30, 2024 | 1.02B | 39.79M | 4.07% |
| Jun 30, 2023 | 977.89M | 35.63M | 3.78% |
| Jun 30, 2022 | 942.26M | 108.91M | 13.07% |
| Jun 30, 2021 | 833.35M | 33.00M | 4.12% |
| Jun 30, 2020 | 800.35M | -27.64M | -3.34% |
| Jun 30, 2019 | 828.00M | 8.01M | 0.98% |
| Jun 30, 2018 | 819.98M | 55.70M | 7.29% |
| Jun 30, 2017 | 764.28M | 12.76M | 1.70% |
| Jun 30, 2016 | 751.53M | 2.94M | 0.39% |
| Jun 30, 2015 | 748.59M | 56.68M | 8.19% |
| Jun 30, 2014 | 691.91M | 38.76M | 5.93% |
| Jun 30, 2013 | 653.15M | -950.00K | -0.15% |
| Jun 30, 2012 | 654.10M | 35.77M | 5.78% |
| Jun 30, 2011 | 618.33M | 253.95M | 69.70% |
| Jun 30, 2005 | 364.38M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Perrigo Company | 4.18B |
| ANI Pharmaceuticals | 923.71M |
| Evotec SE | 859.03M |
| Collegium Pharmaceutical | 796.33M |
| Pacira BioSciences | 734.86M |
| Alvotech | 562.04M |
| HUTCHMED (China) | 548.51M |
| Xeris Biopharma Holdings | 314.85M |
PAHC News
- 16 days ago - Phibro Animal Health Corporation to Participate in Stifel Jaws & Paws Conference - Business Wire
- 24 days ago - Phibro Animal Health price target lowered to $44 from $62 at Citi - TheFly
- 24 days ago - Phibro Animal Health Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 24 days ago - Phibro Animal Health price target lowered to $44 from $62 at Citi - TheFly
- 4 weeks ago - Phibro Animal Health Corporation to Participate in Bank of America Securities Health Care Conference - Business Wire
- 4 weeks ago - Phibro Animal Health Earnings Call Transcript: Q3 2026 - Transcripts
- 4 weeks ago - Phibro Animal Health Quarterly report: Q3 2026 - Filings
- 4 weeks ago - Phibro Animal Health Earnings release: Q3 2026 - Filings